As Ranking Member McCaskill noted in a recent report entitled, "Fueling an Epidemic: Insys Therapeutics and the Systemic Manipulation of Prior Authorization," Insys revenues tripled and profits rose 45 percent between 2013 and 2015.
McCaskill highlights Insys's financial growth amid opioid crisis concerns.
Share
More from Claire McCaskill
This is never a referendum. Presidential elections, by the time they run around, is always, 'well, who do you like slightly better than the two you don't like?' So it is a binary choice.
I think the filibuster is on life support. And I think if the Democrats pick up more seats, I think it will probably go away.
This is really, really bad. What they’re saying is, if you criticize the president of the United States, as an elected member of Congress, we will silence you.
I hope, I hope, I hope Matt keeps saying that everywhere he goes, that abortion really isn't an issue in this election.
Other voices in this conversation
